Kesselheim AS - Search Results

1

The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.

Kesselheim AS. Kesselheim AS. CMAJ. 2011 Sep 6;183(12):1350-1. doi: 10.1503/cmaj.110808. Epub 2011 Jul 11. CMAJ. 2011. PMID: 21746827 Free PMC article. No abstract available.

2

Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, Shrank WH. Kesselheim AS, et al. JAMA. 2008 Dec 3;300(21):2514-26. doi: 10.1001/jama.2008.758. JAMA. 2008. PMID: 19050195 Free PMC article. Review.

3

Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH. Kesselheim AS, et al. Drugs. 2010 Mar 26;70(5):605-21. doi: 10.2165/10898530-000000000-00000. Drugs. 2010. PMID: 20329806 Free PMC article. Review.

4

Covert pharmaceutical promotion in free medical journals.

Kesselheim AS. Kesselheim AS. CMAJ. 2011 Mar 22;183(5):534-5. doi: 10.1503/cmaj.110156. Epub 2011 Feb 28. CMAJ. 2011. PMID: 21398227 Free PMC article. No abstract available.

5

Risk, responsibility, and generic drugs.

Kesselheim AS, Avorn J, Greene JA. Kesselheim AS, et al. N Engl J Med. 2012 Nov 1;367(18):1679-81. doi: 10.1056/NEJMp1208781. N Engl J Med. 2012. PMID: 23113477 Free PMC article. No abstract available.

6

Who is now responsible for discovering and warning about adverse effects of generic drugs?

Kesselheim AS, Green MD, Avorn J. Kesselheim AS, et al. JAMA. 2013 Sep 11;310(10):1023-4. doi: 10.1001/jama.2013.228349. JAMA. 2013. PMID: 23922000 No abstract available.

7

The Food and Drug Administration's role in promoting consistent labels for generic drugs.

Duke JD, Kesselheim AS. Duke JD, et al. Among authors: kesselheim as. JAMA Intern Med. 2014 Aug;174(8):1213-4. doi: 10.1001/jamainternmed.2014.2705. JAMA Intern Med. 2014. PMID: 24957047 No abstract available.

8

Comparative effectiveness of generic versus brand-name antiepileptic medications.

Gagne JJ, Kesselheim AS, Choudhry NK, Polinski JM, Hutchins D, Matlin OS, Brennan TA, Avorn J, Shrank WH. Gagne JJ, et al. Among authors: kesselheim as. Epilepsy Behav. 2015 Nov;52(Pt A):14-8. doi: 10.1016/j.yebeh.2015.08.014. Epub 2015 Sep 19. Epilepsy Behav. 2015. PMID: 26386779

9

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?

Sarpatwari A, Kesselheim AS. Sarpatwari A, et al. Among authors: kesselheim as. PLoS Med. 2016 Feb 9;13(2):e1001955. doi: 10.1371/journal.pmed.1001955. eCollection 2016 Feb. PLoS Med. 2016. PMID: 26859662 Free PMC article. Review.

10

Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.

Kesselheim AS, Gagne JJ, Franklin JM, Eddings W, Fulchino LA, Avorn J, Campbell EG. Kesselheim AS, et al. J Gen Intern Med. 2016 Jun;31(6):609-14. doi: 10.1007/s11606-016-3612-7. Epub 2016 Feb 16. J Gen Intern Med. 2016. PMID: 26883524 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

769 results

Search Page

Filters